Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IB53
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.585 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.651 |
CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.460 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.328 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.328 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.393 |
CLV_PCSK_PC7_1 | 36 | 42 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.339 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.611 |
DOC_MAPK_gen_1 | 35 | 46 | PF00069 | 0.649 |
DOC_MAPK_gen_1 | 79 | 87 | PF00069 | 0.566 |
DOC_MAPK_MEF2A_6 | 39 | 48 | PF00069 | 0.689 |
DOC_MAPK_MEF2A_6 | 86 | 95 | PF00069 | 0.486 |
DOC_PP1_RVXF_1 | 77 | 84 | PF00149 | 0.560 |
DOC_PP2B_LxvP_1 | 69 | 72 | PF13499 | 0.565 |
DOC_USP7_UBL2_3 | 9 | 13 | PF12436 | 0.652 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.334 |
DOC_WW_Pin1_4 | 185 | 190 | PF00397 | 0.351 |
LIG_14-3-3_CanoR_1 | 133 | 140 | PF00244 | 0.275 |
LIG_14-3-3_CanoR_1 | 252 | 258 | PF00244 | 0.641 |
LIG_14-3-3_CanoR_1 | 59 | 66 | PF00244 | 0.619 |
LIG_14-3-3_CanoR_1 | 74 | 83 | PF00244 | 0.527 |
LIG_Clathr_ClatBox_1 | 4 | 8 | PF01394 | 0.600 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.626 |
LIG_LIR_Gen_1 | 124 | 132 | PF02991 | 0.307 |
LIG_LIR_Gen_1 | 191 | 200 | PF02991 | 0.281 |
LIG_LIR_Gen_1 | 239 | 249 | PF02991 | 0.666 |
LIG_LIR_Gen_1 | 63 | 73 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 191 | 196 | PF02991 | 0.321 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.528 |
LIG_PDZ_Class_1 | 253 | 258 | PF00595 | 0.641 |
LIG_SH2_CRK | 66 | 70 | PF00017 | 0.561 |
LIG_SH2_NCK_1 | 134 | 138 | PF00017 | 0.315 |
LIG_SH2_STAP1 | 125 | 129 | PF00017 | 0.358 |
LIG_SH2_STAP1 | 134 | 138 | PF00017 | 0.279 |
LIG_SH2_STAP1 | 66 | 70 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.607 |
LIG_SH3_1 | 183 | 189 | PF00018 | 0.356 |
LIG_SH3_3 | 183 | 189 | PF00018 | 0.410 |
LIG_SUMO_SIM_anti_2 | 97 | 103 | PF11976 | 0.407 |
LIG_SUMO_SIM_par_1 | 100 | 106 | PF11976 | 0.405 |
LIG_SUMO_SIM_par_1 | 218 | 226 | PF11976 | 0.620 |
LIG_SUMO_SIM_par_1 | 91 | 97 | PF11976 | 0.330 |
LIG_TRAF2_1 | 189 | 192 | PF00917 | 0.389 |
LIG_TRAF2_1 | 234 | 237 | PF00917 | 0.616 |
LIG_TYR_ITIM | 198 | 203 | PF00017 | 0.306 |
LIG_UBA3_1 | 26 | 35 | PF00899 | 0.572 |
LIG_UBA3_1 | 4 | 9 | PF00899 | 0.621 |
LIG_ULM_U2AF65_1 | 79 | 84 | PF00076 | 0.532 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.622 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.380 |
MOD_CK2_1 | 231 | 237 | PF00069 | 0.667 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.524 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.612 |
MOD_PIKK_1 | 250 | 256 | PF00454 | 0.657 |
MOD_PKA_1 | 35 | 41 | PF00069 | 0.603 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.270 |
MOD_PKA_2 | 35 | 41 | PF00069 | 0.697 |
MOD_Plk_4 | 103 | 109 | PF00069 | 0.410 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.328 |
MOD_ProDKin_1 | 185 | 191 | PF00069 | 0.352 |
MOD_SUMO_for_1 | 145 | 148 | PF00179 | 0.358 |
TRG_DiLeu_BaEn_3 | 236 | 242 | PF01217 | 0.631 |
TRG_DiLeu_BaEn_4 | 191 | 197 | PF01217 | 0.340 |
TRG_DiLeu_BaLyEn_6 | 22 | 27 | PF01217 | 0.590 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.270 |
TRG_ENDOCYTIC_2 | 195 | 198 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.525 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.606 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.332 |
TRG_ER_diArg_1 | 39 | 41 | PF00400 | 0.638 |
TRG_ER_diArg_1 | 79 | 82 | PF00400 | 0.521 |
TRG_NES_CRM1_1 | 152 | 165 | PF08389 | 0.341 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNI9 | Bodo saltans | 31% | 72% |
A0A1X0P730 | Trypanosomatidae | 46% | 73% |
A4H9P2 | Leishmania braziliensis | 80% | 100% |
A4HY09 | Leishmania infantum | 100% | 100% |
D0A587 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 74% |
E9ARS3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QDQ0 | Leishmania major | 96% | 100% |
V5BEH9 | Trypanosoma cruzi | 45% | 91% |